BioLineRx (BLRX) Capital Expenditures (2013 - 2026)
BioLineRx (BLRX) posted Capital Expenditures of -$6,000 for the quarter ended Mar 31, 2026.
Powered by 
Analysis
BioLineRx (BLRX) Capital Expenditures (2013 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Capital Expenditures at BioLineRx was -$27,000; for the year ended Dec 31, 2025, it was -$25,000.
- In prior years, BioLineRx's Capital Expenditures was -$53,000 in the year ended Dec 31, 2024, -$116,000 in the year ended Dec 31, 2023, -$131,000 in the year ended Dec 31, 2022 and -$97,000 in the year ended Dec 31, 2021.
- The figure for the quarter ended Mar 31, 2026 stands as the highest quarterly Capital Expenditures since the quarter ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | BioLineRx | 6.34 Bn | 6.35 Bn | 235,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Jun 30, 2024 | -27,000.00 |
| Mar 31, 2024 | -32,000.00 |
| Dec 31, 2023 | -16,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -67,000.00 |
| Mar 31, 2023 | -32,000.00 |
| Dec 31, 2022 | -57,000.00 |
| Sep 30, 2022 | -12,000.00 |
| Jun 30, 2022 | -44,000.00 |
| Mar 31, 2022 | -18,000.00 |
| Dec 31, 2021 | -62,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | -19,000.00 |
| Mar 31, 2021 | -19,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2019 | -13,000.00 |
| Sep 30, 2019 | -1,000.00 |
| Jun 30, 2019 | -22,000.00 |
API Access
BioLineRx Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();